SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-023874
Filing Date
2024-05-17
Accepted
2024-05-16 19:18:55
Documents
95
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ffntf-20240331.htm   iXBRL 10-Q 985477
2 EX-31.1 ffntf03312024exhibit311.htm EX-31.1 12736
3 EX-31.2 ffntf03312024exhibit312.htm EX-31.2 12948
4 EX-32.1 ffntf03312024exhibit321.htm EX-32.1 12038
  Complete submission text file 0001628280-24-023874.txt   7359644

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ffntf-20240331.xsd EX-101.SCH 73163
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ffntf-20240331_cal.xml EX-101.CAL 105735
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ffntf-20240331_def.xml EX-101.DEF 317627
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ffntf-20240331_lab.xml EX-101.LAB 689116
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ffntf-20240331_pre.xml EX-101.PRE 501674
99 EXTRACTED XBRL INSTANCE DOCUMENT ffntf-20240331_htm.xml XML 958307
Mailing Address 7010 E. CHAUNCEY LANE STE. 235 PHOENIX AZ 85054
Business Address 7010 E. CHAUNCEY LANE STE. 235 PHOENIX AZ 85054 (602) 633-3067
4Front Ventures Corp. (Filer) CIK: 0001783875 (see all company filings)

IRS No.: 834168417 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56075 | Film No.: 24957323
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)